Suppr超能文献

降血脂药物治疗后大鼠和豚鼠过氧化物酶体β-氧化、棕榈酰辅酶A水解酶、胞质和微粒体环氧化物水解酶的时间依赖性和差异诱导作用

Time-dependence and differential induction of rat and guinea pig peroxisomal beta-oxidation, palmitoyl-CoA hydrolase, cytosolic and microsomal epoxide hydrolase after treatment with hypolipidemic drugs.

作者信息

Oesch F, Hartmann R, Timms C, Strolin-Benedetti M, Dostert P, Wörner W, Schladt L

机构信息

Institut für Toxikologie, Universität Mainz, Federal Republic of Germany.

出版信息

J Cancer Res Clin Oncol. 1988;114(4):341-6. doi: 10.1007/BF02128176.

Abstract

Fischer-344 rats and Hartley guinea pigs received a diet containing 0.01% (w/w), 0.05% (w/w), or 0.25% (w/w) of the hypolipidemic drug fenofibrate. Rats were treated for 4, 7, 14, or 21 days, and a clear dose-dependent and weak time-dependent increase in liver/body weight ratio was observed. The specific activity of peroxisomal beta-oxidation increased linearly with time at all concentrations used. A dose-dependent increase in cEH was observed, but the activity remained constant after treatment for 7 days. Enhancement of palmitoyl-CoA hydrolase was dose-dependent, but was similar at all 4 time points investigated. In contrast to the other enzyme activities, mEH was not or only minimally (less than 1.5-fold) induced. In contrast to the rat, treatment of guinea pigs with fenofibrate for 1 week did not change liver weight or enzyme activities. Prolonged treatment of guinea pigs (4 weeks) with fenofibrate did not result in an increase in enzyme activities. This was also observed with clofibrate whereas tiadenol caused a slight increase in enzyme activities (1.5- to 2.6-fold). In contrast to the guinea pig each of the three hypolipidemic drugs led to an increase in enzyme activities in the rat liver after treatment for 1 week.

摘要

将高脂血症药物非诺贝特按0.01%(重量/重量)、0.05%(重量/重量)或0.25%(重量/重量)添加到饲料中,分别喂饲费希尔344大鼠和哈特利豚鼠。大鼠接受4天、7天、14天或21天的处理,结果观察到肝/体重比呈明显的剂量依赖性增加,且时间依赖性较弱。在所使用的所有浓度下,过氧化物酶体β氧化的比活性均随时间呈线性增加。观察到羧酸酯酶(cEH)呈剂量依赖性增加,但在处理7天后其活性保持恒定。棕榈酰辅酶A水解酶的增强呈剂量依赖性,但在所有4个研究时间点均相似。与其他酶活性不同,微粒体环氧水解酶(mEH)未被诱导或仅被轻微诱导(小于1.5倍)。与大鼠不同,用非诺贝特处理豚鼠1周未改变肝脏重量或酶活性。用非诺贝特对豚鼠进行长期处理(4周)未导致酶活性增加。氯贝丁酯也观察到了这种情况,而噻二诺则使酶活性略有增加(1.5至2.6倍)。与豚鼠不同,三种高脂血症药物中的每一种在处理大鼠1周后均导致大鼠肝脏酶活性增加。

相似文献

3
Coordinate induction of peroxisomal beta-oxidation activity and cytosolic epoxide hydrolase activity.
Pharmacol Ther. 1987;33(1):29-35. doi: 10.1016/0163-7258(87)90024-6.
6
Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats.
Biochem Pharmacol. 1986 Oct 1;35(19):3309-16. doi: 10.1016/0006-2952(86)90428-4.
7
Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
Biochem Pharmacol. 1989 Jun 15;38(12):1963-9. doi: 10.1016/0006-2952(89)90495-4.

本文引用的文献

1
Changes in lipid metabolizing enzymes of hepatic subcellular fractions from rats treated with tiadenol and clofibrate.
Biochem Pharmacol. 1981 Aug 15;30(16):2251-6. doi: 10.1016/0006-2952(81)90095-2.
3
Fenofibrate and human liver. Lack of proliferation of peroxisomes.
Arch Toxicol. 1983 Jun;53(2):151-63. doi: 10.1007/BF00302723.
4
Epoxide hydrolase activity in isolated peroxisomes of mouse liver.
FEBS Lett. 1983 Jul 25;158(2):225-8. doi: 10.1016/0014-5793(83)80583-3.
9
Factors influencing peroxisome proliferation in cultured rat hepatocytes.
Arch Toxicol. 1984 Oct;55(4):239-46. doi: 10.1007/BF00341018.
10
Clobuzarit: species differences in the morphological and biochemical response of the liver following chronic administration.
Toxicol Appl Pharmacol. 1984 Mar 30;73(1):138-51. doi: 10.1016/0041-008x(84)90062-0.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验